Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for CureVac (CVAC) over the last 5 years, with Q3 2025 value amounting to 0.24%.

  • CureVac's Return on Capital Employed rose 100.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.24% for FY2024, which is 6900.0% up from last year.
  • Per CureVac's latest filing, its Return on Capital Employed stood at 0.24% for Q3 2025, which was up 100.0% from 0.33% recorded in Q2 2025.
  • In the past 5 years, CureVac's Return on Capital Employed ranged from a high of 0.33% in Q2 2025 and a low of 0.56% during Q2 2024
  • Moreover, its 5-year median value for Return on Capital Employed was 0.35% (2023), whereas its average is 0.2%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -2300bps in 2023, then surged by 8900bps in 2025.
  • CureVac's Return on Capital Employed (Quarter) stood at 0.4% in 2021, then increased by 12bps to 0.35% in 2022, then fell by -24bps to 0.43% in 2023, then surged by 156bps to 0.24% in 2024, then dropped by 0bps to 0.24% in 2025.
  • Its last three reported values are 0.24% in Q3 2025, 0.33% for Q2 2025, and 0.29% during Q1 2025.